Sanofi weighs takeover of US drugmaker Insmed, Bloomberg News reports
10 Articles
10 Articles
Sanofi reportedly weighs Insmed takeover
Sanofi is weighing an acquisition of U.S. drugmaker Insmed, a potential deal that could rank among the largest biopharmaceutical transactions in recent years. Discussions are ongoing, no agreement is assured, and Insmed shares rose after the report. · 15 sources across the spectrum on IJR News.
Sanofi weighs takeover of US drugmaker Insmed, Bloomberg News reports - Regional Media News
Nov 19 (Reuters) - Sanofi is weighing an acquisition of US drugmaker Insmed, Bloomberg News reported on Thursday, citing people familiar with the matter. Shares of Insmed, which has a market valuation of $26.28 billion according to LSEG data, were up 14%. Insmed did not [...]
According to a Bloomberg report, the pharmaceutical company Sanofi is examining a takeover of the US pharmaceutical company Insmed. It would be the biggest deal in the biopharma industry for years.
Coverage Details
Bias Distribution
- 75% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium













